Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis

The most abundant populations of non-neoplastic cells in the glioblastoma (GBM) microenvironment are resident microglia, macrophages and infiltrating monocytes from the blood circulation. The mechanisms by which monocytes infiltrate into GBM, their fate following infiltration, and their role in GBM...

Full description

Saved in:
Bibliographic Details
Published inOncotarget Vol. 6; no. 17; pp. 15077 - 15094
Main Authors Feng, Xi, Szulzewsky, Frank, Yerevanian, Alexan, Chen, Zhihong, Heinzmann, David, Rasmussen, Rikke Darling, Alvarez-Garcia, Virginia, Kim, Yeonghwan, Wang, Bingcheng, Tamagno, Ilaria, Zhou, Hao, Li, Xiaoxia, Kettenmann, Helmut, Ransohoff, Richard M, Hambardzumyan, Dolores
Format Journal Article
LanguageEnglish
Published United States Impact Journals LLC 20.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The most abundant populations of non-neoplastic cells in the glioblastoma (GBM) microenvironment are resident microglia, macrophages and infiltrating monocytes from the blood circulation. The mechanisms by which monocytes infiltrate into GBM, their fate following infiltration, and their role in GBM growth are not known. Here we tested the hypothesis that loss of the fractalkine receptor CX3CR1 in microglia and monocytes would affect gliomagenesis. Deletion of Cx3cr1 from the microenvironment resulted in increased tumor incidence and shorter survival times in glioma-bearing mice. Loss of Cx3cr1 did not affect accumulation of microglia/macrophages in peri-tumoral areas, but instead indirectly promoted the trafficking of CD11b+CD45hiCX3CR1lowLy-6ChiLy-6G-F4/80-/low circulating inflammatory monocytes into the CNS, resulting in their increased accumulation in the perivascular area. Cx3cr1-deficient microglia/macrophages and monocytes demonstrated upregulation of IL1β expression that was inversely proportional to Cx3cr1 gene dosage. The Proneural subgroup of the TCGA GBM patient dataset with high IL1β expression showed shorter survival compared to patients with low IL1β. IL1β promoted tumor growth and increased the cancer stem cell phenotype in murine and human Proneural glioma stem cells (GSCs). IL1β activated the p38 MAPK signaling pathway and expression of monocyte chemoattractant protein (MCP-1/CCL2) by tumor cells. Loss of Cx3cr1 in microglia in a monocyte-free environment had no impact on tumor growth and did not alter microglial migration. These data suggest that enhancing signaling to CX3CR1 or inhibiting IL1β signaling in intra-tumoral macrophages can be considered as potential strategies to decrease the tumor-promoting effects of monocytes in Proneural GBM.
AbstractList The most abundant populations of non-neoplastic cells in the glioblastoma (GBM) microenvironment are resident microglia, macrophages and infiltrating monocytes from the blood circulation. The mechanisms by which monocytes infiltrate into GBM, their fate following infiltration, and their role in GBM growth are not known. Here we tested the hypothesis that loss of the fractalkine receptor CX3CR1 in microglia and monocytes would affect gliomagenesis. Deletion of Cx3cr1 from the microenvironment resulted in increased tumor incidence and shorter survival times in glioma-bearing mice. Loss of Cx3cr1 did not affect accumulation of microglia/macrophages in peri-tumoral areas, but instead indirectly promoted the trafficking of CD11b + CD45 hi CX3CR1 low Ly-6C hi Ly-6G − F4/80 −/low circulating inflammatory monocytes into the CNS, resulting in their increased accumulation in the perivascular area. Cx3cr1-deficient microglia/macrophages and monocytes demonstrated upregulation of IL1β expression that was inversely proportional to Cx3cr1 gene dosage. The Proneural subgroup of the TCGA GBM patient dataset with high IL1β expression showed shorter survival compared to patients with low IL1β. IL1β promoted tumor growth and increased the cancer stem cell phenotype in murine and human Proneural glioma stem cells (GSCs). IL1β activated the p38 MAPK signaling pathway and expression of monocyte chemoattractant protein (MCP-1/CCL2) by tumor cells. Loss of Cx3cr1 in microglia in a monocyte-free environment had no impact on tumor growth and did not alter microglial migration. These data suggest that enhancing signaling to CX3CR1 or inhibiting IL1β signaling in intra-tumoral macrophages can be considered as potential strategies to decrease the tumor-promoting effects of monocytes in Proneural GBM.
The most abundant populations of non-neoplastic cells in the glioblastoma (GBM) microenvironment are resident microglia, macrophages and infiltrating monocytes from the blood circulation. The mechanisms by which monocytes infiltrate into GBM, their fate following infiltration, and their role in GBM growth are not known. Here we tested the hypothesis that loss of the fractalkine receptor CX3CR1 in microglia and monocytes would affect gliomagenesis. Deletion of Cx3cr1 from the microenvironment resulted in increased tumor incidence and shorter survival times in glioma-bearing mice. Loss of Cx3cr1 did not affect accumulation of microglia/macrophages in peri-tumoral areas, but instead indirectly promoted the trafficking of CD11b+CD45hiCX3CR1lowLy-6ChiLy-6G-F4/80-/low circulating inflammatory monocytes into the CNS, resulting in their increased accumulation in the perivascular area. Cx3cr1-deficient microglia/macrophages and monocytes demonstrated upregulation of IL1β expression that was inversely proportional to Cx3cr1 gene dosage. The Proneural subgroup of the TCGA GBM patient dataset with high IL1β expression showed shorter survival compared to patients with low IL1β. IL1β promoted tumor growth and increased the cancer stem cell phenotype in murine and human Proneural glioma stem cells (GSCs). IL1β activated the p38 MAPK signaling pathway and expression of monocyte chemoattractant protein (MCP-1/CCL2) by tumor cells. Loss of Cx3cr1 in microglia in a monocyte-free environment had no impact on tumor growth and did not alter microglial migration. These data suggest that enhancing signaling to CX3CR1 or inhibiting IL1β signaling in intra-tumoral macrophages can be considered as potential strategies to decrease the tumor-promoting effects of monocytes in Proneural GBM.
Author Feng, Xi
Szulzewsky, Frank
Rasmussen, Rikke Darling
Kettenmann, Helmut
Li, Xiaoxia
Kim, Yeonghwan
Tamagno, Ilaria
Heinzmann, David
Chen, Zhihong
Alvarez-Garcia, Virginia
Wang, Bingcheng
Zhou, Hao
Ransohoff, Richard M
Yerevanian, Alexan
Hambardzumyan, Dolores
AuthorAffiliation 2 Cellular Neurosciences, Max Delbrück Center for Molecular Medicine, Berlin, Germany
6 Rammelkamp Center for Research, MetroHealth Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
7 Department of Immunology at Cleveland Clinic, Cleveland, Ohio, USA
1 Department of Neurosciences at Cleveland Clinic, Cleveland, Ohio, USA
3 Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
5 Department of Stem Cell Biology and Regenerative Medicine, Cleveland, Ohio, USA
8 Neuroinflammation Research Center, Cleveland Clinic, Cleveland, Ohio, USA
4 Department of Cardiology at Tübingen University School of Medicine, Tübingen, Germany
AuthorAffiliation_xml – name: 7 Department of Immunology at Cleveland Clinic, Cleveland, Ohio, USA
– name: 4 Department of Cardiology at Tübingen University School of Medicine, Tübingen, Germany
– name: 5 Department of Stem Cell Biology and Regenerative Medicine, Cleveland, Ohio, USA
– name: 6 Rammelkamp Center for Research, MetroHealth Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
– name: 1 Department of Neurosciences at Cleveland Clinic, Cleveland, Ohio, USA
– name: 8 Neuroinflammation Research Center, Cleveland Clinic, Cleveland, Ohio, USA
– name: 2 Cellular Neurosciences, Max Delbrück Center for Molecular Medicine, Berlin, Germany
– name: 3 Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
Author_xml – sequence: 1
  givenname: Xi
  surname: Feng
  fullname: Feng, Xi
  organization: Department of Neurosciences at Cleveland Clinic, Cleveland, Ohio, USA
– sequence: 2
  givenname: Frank
  surname: Szulzewsky
  fullname: Szulzewsky, Frank
  organization: Cellular Neurosciences, Max Delbrück Center for Molecular Medicine, Berlin, Germany
– sequence: 3
  givenname: Alexan
  surname: Yerevanian
  fullname: Yerevanian, Alexan
  organization: Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
– sequence: 4
  givenname: Zhihong
  surname: Chen
  fullname: Chen, Zhihong
  organization: Department of Neurosciences at Cleveland Clinic, Cleveland, Ohio, USA
– sequence: 5
  givenname: David
  surname: Heinzmann
  fullname: Heinzmann, David
  organization: Department of Cardiology at Tübingen University School of Medicine, Tübingen, Germany
– sequence: 6
  givenname: Rikke Darling
  surname: Rasmussen
  fullname: Rasmussen, Rikke Darling
  organization: Department of Neurosciences at Cleveland Clinic, Cleveland, Ohio, USA
– sequence: 7
  givenname: Virginia
  surname: Alvarez-Garcia
  fullname: Alvarez-Garcia, Virginia
  organization: Department of Neurosciences at Cleveland Clinic, Cleveland, Ohio, USA
– sequence: 8
  givenname: Yeonghwan
  surname: Kim
  fullname: Kim, Yeonghwan
  organization: Department of Stem Cell Biology and Regenerative Medicine, Cleveland, Ohio, USA
– sequence: 9
  givenname: Bingcheng
  surname: Wang
  fullname: Wang, Bingcheng
  organization: Rammelkamp Center for Research, MetroHealth Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
– sequence: 10
  givenname: Ilaria
  surname: Tamagno
  fullname: Tamagno, Ilaria
  organization: Department of Neurosciences at Cleveland Clinic, Cleveland, Ohio, USA
– sequence: 11
  givenname: Hao
  surname: Zhou
  fullname: Zhou, Hao
  organization: Department of Immunology at Cleveland Clinic, Cleveland, Ohio, USA
– sequence: 12
  givenname: Xiaoxia
  surname: Li
  fullname: Li, Xiaoxia
  organization: Department of Immunology at Cleveland Clinic, Cleveland, Ohio, USA
– sequence: 13
  givenname: Helmut
  surname: Kettenmann
  fullname: Kettenmann, Helmut
  organization: Cellular Neurosciences, Max Delbrück Center for Molecular Medicine, Berlin, Germany
– sequence: 14
  givenname: Richard M
  surname: Ransohoff
  fullname: Ransohoff, Richard M
  organization: Neuroinflammation Research Center, Cleveland Clinic, Cleveland, Ohio, USA
– sequence: 15
  givenname: Dolores
  surname: Hambardzumyan
  fullname: Hambardzumyan, Dolores
  organization: Department of Neurosciences at Cleveland Clinic, Cleveland, Ohio, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25987130$$D View this record in MEDLINE/PubMed
BookMark eNpVUU1LAzEQDVKxtfbuSfbopTUfm93sRZDiFxQEURAvIWZna2ST1GRX6L9319Za5zIzzJs3w3vHaOC8A4ROCZ4RkTF64Z32jQpLaGYsZ_gAjUiRFlPKORvs1UM0ifEDd8HTXNDiCA0pL0ROGB6h14WPMfFVMn9h80eSGKcDqAgxUVq3tq1VY7zrAcZVtbJWNT6sE-ud1-umh7kyWQVvfd8sa-OtWoKDaOIJOqxUHWGyzWP0fHP9NL-bLh5u7-dXi6lOM9pMieBaYSCke49gwYnSGLNSsCzLS8ExzipIC5yLQlS0wDrXpRYlh5QKoJASNkaXG95V-2ah1OCaoGq5CsaqsJZeGfl_4sy7XPovmXIuSKfcGJ1vCYL_bCE20pqooa6VA99GSbIizTGnWHRQvIHq0OkWoNqdIVj-uCL_XJG9K93K2f57u4VfD9g3jFOOEQ
CitedBy_id crossref_primary_10_3389_fonc_2021_788365
crossref_primary_10_1021_acsami_1c12406
crossref_primary_10_1007_s10555_018_9766_5
crossref_primary_10_3389_fphar_2019_00506
crossref_primary_10_3390_cancers13184548
crossref_primary_10_1093_neuonc_noaa075
crossref_primary_10_1016_j_drup_2018_03_003
crossref_primary_10_1186_s13046_022_02535_7
crossref_primary_10_3390_ijms21103723
crossref_primary_10_3390_biom12060850
crossref_primary_10_1111_imm_13135
crossref_primary_10_1371_journal_pone_0167440
crossref_primary_10_3389_fonc_2023_1236268
crossref_primary_10_1016_j_neuint_2021_105168
crossref_primary_10_3390_cells10030621
crossref_primary_10_1093_neuonc_noz080
crossref_primary_10_1038_s41598_018_34242_9
crossref_primary_10_18632_oncotarget_7992
crossref_primary_10_3390_ijms19010147
crossref_primary_10_3389_fphar_2020_00368
crossref_primary_10_1101_gad_310797_117
crossref_primary_10_2478_acb_2024_0001
crossref_primary_10_1016_j_trecan_2015_10_009
crossref_primary_10_1016_j_cca_2021_02_005
crossref_primary_10_1073_pnas_1902366116
crossref_primary_10_3389_fonc_2022_822085
crossref_primary_10_3390_ijms20174307
crossref_primary_10_1016_j_ultrasmedbio_2022_12_006
crossref_primary_10_5005_jp_journals_10085_5111
crossref_primary_10_1038_s41598_020_76657_3
crossref_primary_10_1007_s12672_021_00423_8
crossref_primary_10_3390_ijms22010194
crossref_primary_10_1016_j_ccell_2016_05_017
crossref_primary_10_1016_j_ebiom_2018_02_024
crossref_primary_10_1002_glia_23014
crossref_primary_10_1186_s12974_020_01797_2
crossref_primary_10_1038_s41467_023_37361_8
crossref_primary_10_3389_fimmu_2018_01004
crossref_primary_10_3390_ijms23084166
crossref_primary_10_1186_s40478_023_01605_x
crossref_primary_10_1093_brain_aww046
crossref_primary_10_3389_fonc_2022_1022716
crossref_primary_10_3390_cancers15143722
crossref_primary_10_3390_cancers16030603
crossref_primary_10_1007_s10555_022_10051_5
crossref_primary_10_1016_j_xcrm_2023_101373
crossref_primary_10_1038_nn_4185
crossref_primary_10_3390_cancers13174357
crossref_primary_10_1016_j_bbcan_2017_05_007
crossref_primary_10_3892_ijmm_2018_3668
crossref_primary_10_1038_onc_2017_129
crossref_primary_10_1016_j_neo_2021_09_001
crossref_primary_10_1093_noajnl_vdaa127
crossref_primary_10_3390_brainsci12040505
crossref_primary_10_2174_1573395515666190611122818
crossref_primary_10_5306_wjco_v14_i3_117
crossref_primary_10_1093_neuonc_noaa185
crossref_primary_10_3390_ijms23052509
crossref_primary_10_1155_2017_9634172
crossref_primary_10_1002_EXP_20210166
crossref_primary_10_1038_s41419_023_05753_9
crossref_primary_10_3390_cancers12071960
crossref_primary_10_1038_nrclinonc_2016_217
crossref_primary_10_3389_fimmu_2023_994698
crossref_primary_10_1002_glia_22945
crossref_primary_10_3389_fimmu_2016_00156
crossref_primary_10_3389_fimmu_2019_02294
crossref_primary_10_1038_s41467_020_16789_2
crossref_primary_10_3390_cancers14143331
crossref_primary_10_3389_fonc_2021_766656
crossref_primary_10_1021_acsami_2c16586
crossref_primary_10_1016_j_canlet_2018_07_034
crossref_primary_10_3390_ijms21165838
crossref_primary_10_3389_fonc_2017_00120
crossref_primary_10_3390_ijms22073301
crossref_primary_10_1038_s41571_021_00518_9
crossref_primary_10_3390_cancers11010005
crossref_primary_10_1002_glia_23984
crossref_primary_10_3390_brainsci12060718
crossref_primary_10_1111_bpa_12788
crossref_primary_10_1111_neup_12354
crossref_primary_10_3389_fimmu_2022_932938
crossref_primary_10_1371_journal_pone_0182643
crossref_primary_10_3390_biom13071084
crossref_primary_10_1016_j_ymthe_2018_06_014
crossref_primary_10_3389_fgene_2020_604655
crossref_primary_10_3389_fonc_2022_969787
crossref_primary_10_3390_neurolint15020037
crossref_primary_10_3389_fncel_2022_1002487
crossref_primary_10_1186_s12974_017_0830_9
crossref_primary_10_1016_j_prp_2022_153813
crossref_primary_10_3390_ph13110389
crossref_primary_10_1016_j_jneuroim_2021_577633
crossref_primary_10_1155_2022_8903482
crossref_primary_10_1038_s41467_019_10458_9
crossref_primary_10_3389_fimmu_2023_1191838
crossref_primary_10_1186_s13059_017_1362_4
crossref_primary_10_1080_14737175_2018_1510321
crossref_primary_10_1073_pnas_1910856117
crossref_primary_10_1172_JCI163802
crossref_primary_10_1016_j_neucom_2020_10_117
crossref_primary_10_3390_cancers13164004
crossref_primary_10_1099_jgv_0_000667
crossref_primary_10_1158_0008_5472_CAN_16_2310
crossref_primary_10_1002_glia_23696
crossref_primary_10_1155_2020_8844313
crossref_primary_10_1084_jem_20191131
crossref_primary_10_1080_2162402X_2019_1655360
crossref_primary_10_3389_fonc_2018_00049
crossref_primary_10_1016_j_canlet_2021_12_008
crossref_primary_10_1007_s00401_021_02401_4
crossref_primary_10_3390_ijms19020436
crossref_primary_10_1097_MOG_0000000000000317
crossref_primary_10_1002_glia_22994
crossref_primary_10_1016_j_pharmthera_2020_107790
crossref_primary_10_1111_jvim_13983
crossref_primary_10_3389_fimmu_2021_730289
crossref_primary_10_3390_brainsci13040542
crossref_primary_10_3389_fimmu_2020_571951
crossref_primary_10_3390_ijms19010127
crossref_primary_10_1111_bpa_12927
crossref_primary_10_1186_s40478_021_01156_z
crossref_primary_10_3389_fonc_2020_00092
crossref_primary_10_1186_s13058_021_01412_z
crossref_primary_10_1002_ijc_33276
crossref_primary_10_1007_s12035_022_02996_z
crossref_primary_10_3390_nu11061343
Cites_doi 10.1038/nn.2887
10.1038/nature09615
10.1038/nn1715
10.1056/NEJMoa043330
10.1038/jcbfm.2008.64
10.1073/pnas.0804273106
10.4049/jimmunol.169.5.2264
10.1016/j.jneuroim.2008.04.016
10.1007/978-1-62703-128-8_11
10.1126/scisignal.2004088
10.1016/j.stem.2009.01.007
10.1186/scrt96
10.1038/nature07385
10.1007/s12015-008-9021-5
10.1007/s00011-012-0501-3
10.1016/j.ccr.2013.08.001
10.1073/pnas.95.18.10896
10.1016/j.cell.2013.09.034
10.1158/2159-8290.CD-12-0095
10.1158/0008-5472.CAN-07-6350
10.1158/1535-7163.MCT-06-0711
10.1016/j.neo.2014.03.006
10.1200/JCO.2008.17.2833
10.1128/MCB.20.11.4106-4114.2000
10.1016/j.ccr.2009.12.020
10.1182/blood-2013-01-480749
10.1016/j.stem.2014.01.005
10.1016/j.immuni.2012.12.001
10.1126/science.1194637
10.1371/journal.pone.0057230
10.2353/ajpath.2010.100265
10.1593/tlo.09100
10.1002/glia.21264
10.1016/j.celrep.2012.12.013
10.1002/ana.23813
10.1016/j.ccr.2006.11.020
10.1016/j.stem.2010.01.001
10.1523/JNEUROSCI.0539-12.2012
10.1016/j.ccr.2006.02.019
10.1038/nature03128
10.1371/journal.pone.0023902
10.1038/nri3070
ContentType Journal Article
Copyright Copyright: © 2015 Feng et al. 2015
Copyright_xml – notice: Copyright: © 2015 Feng et al. 2015
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.18632/oncotarget.3730
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1949-2553
EndPage 15094
ExternalDocumentID 10_18632_oncotarget_3730
25987130
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: U01 CA160882
– fundername: NCI NIH HHS
  grantid: U01CA160882
– fundername: NHLBI NIH HHS
  grantid: P01 HL029582
GroupedDBID ---
53G
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CGR
CUY
CVF
DIK
ECM
EIF
FRJ
GX1
HYE
KQ8
M48
M~E
NPM
OK1
PGMZT
RPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c462t-185ca0e1105410851ac003d83667d85006fe4907898f290c7cdc8d5e428e2e413
IEDL.DBID RPM
ISSN 1949-2553
IngestDate Tue Sep 17 21:01:57 EDT 2024
Fri Aug 16 11:32:44 EDT 2024
Fri Aug 23 00:23:59 EDT 2024
Sat Sep 28 08:08:35 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 17
Keywords monocyte
CX3CR1/CX3CL1 signaling
glioblastoma
microglia
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-185ca0e1105410851ac003d83667d85006fe4907898f290c7cdc8d5e428e2e413
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558137/
PMID 25987130
PQID 1694705208
PQPubID 23479
PageCount 18
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4558137
proquest_miscellaneous_1694705208
crossref_primary_10_18632_oncotarget_3730
pubmed_primary_25987130
PublicationCentury 2000
PublicationDate 2015-06-20
PublicationDateYYYYMMDD 2015-06-20
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-06-20
  day: 20
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Oncotarget
PublicationTitleAlternate Oncotarget
PublicationYear 2015
Publisher Impact Journals LLC
Publisher_xml – name: Impact Journals LLC
References 23550210 - Sci Signal. 2013 Apr 2;6(269):pl1
21068834 - Nature. 2010 Nov 11;468(7321):253-62
23077045 - J Neurosci. 2012 Oct 17;32(42):14592-601
23273845 - Immunity. 2013 Jan 24;38(1):79-91
23424002 - Ann Neurol. 2013 Feb;73(2):303-8
23775714 - Blood. 2013 Aug 1;122(5):674-83
16530701 - Cancer Cell. 2006 Mar;9(3):157-73
22330721 - Stem Cell Res Ther. 2012;3(1):5
22706317 - Inflamm Res. 2012 Oct;61(10):1085-92
21901144 - PLoS One. 2011;6(8):e23902
18595010 - Stem Cell Rev. 2008 Sep;4(3):203-10
20086236 - Sci Signal. 2010;3(105):cm2
24120142 - Cell. 2013 Oct 10;155(2):462-77
16732273 - Nat Neurosci. 2006 Jul;9(7):917-24
22588877 - Cancer Discov. 2012 May;2(5):401-4
20129251 - Cancer Cell. 2010 Jan 19;17(1):98-110
24607407 - Cell Stem Cell. 2014 Mar 6;14(3):357-69
10805752 - Mol Cell Biol. 2000 Jun;20(11):4106-14
20144787 - Cell Stem Cell. 2010 Feb 5;6(2):141-52
19412424 - Transl Oncol. 2009 May;2(2):89-95
17406030 - Mol Cancer Ther. 2007 Apr;6(4):1212-22
18772890 - Nature. 2008 Oct 23;455(7216):1061-8
15758009 - N Engl J Med. 2005 Mar 10;352(10):987-96
22379614 - Glia. 2012 Mar;60(3):502-14
18381430 - Cancer Res. 2008 Apr 1;68(7):2241-9
20864679 - Am J Pathol. 2010 Nov;177(5):2549-62
23993863 - Cancer Cell. 2013 Sep 9;24(3):331-46
12193691 - J Immunol. 2002 Sep 1;169(5):2264-73
15549107 - Nature. 2004 Nov 18;432(7015):396-401
21984070 - Nat Rev Immunol. 2011 Nov;11(11):762-74
17222791 - Cancer Cell. 2007 Jan;11(1):69-82
24726753 - Neoplasia. 2014 Mar;16(3):193-206, 206.e19-25
20966214 - Science. 2010 Nov 5;330(6005):841-5
18575457 - J Cereb Blood Flow Metab. 2008 Oct;28(10):1707-21
23437346 - PLoS One. 2013;8(2):e57230
10764271 - Neurosurgery. 2000 Apr;46(4):957-61; discussion 961-2
19617536 - Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12530-5
18508133 - J Neuroimmunol. 2008 Jul 31;198(1-2):98-105
9724801 - Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10896-901
19265662 - Cell Stem Cell. 2009 Mar 6;4(3):226-35
21804537 - Nat Neurosci. 2011 Sep;14(9):1142-9
23179832 - Methods Mol Biol. 2013;946:163-79
23333277 - Cell Rep. 2013 Jan 31;3(1):260-73
19001328 - J Clin Oncol. 2008 Dec 20;26(36):5957-64
Pietras (12) 2014; 14
Charles (16) 2010; 6
Ginhoux (35) 2010; 330
Becher (6) 2008; 68
Lee (20) 2010; 177
Kumar (39) 2013; 8
Stupp (1) 2005; 352
Gutmann (33) 2013; 73
Markovic (8) 2009; 106
Brennan (5) 2013; 155
Re (42) 2002; 169
Verhaak (3) 2010; 17
Cardona (10) 2010; 468
Joo (31) 2013; 3
Cerami (44) 2012; 2
Morganti (21) 2012; 32
Calabrese (15) 2007; 11
Wang (41) 2012; 3
Rodero (36) 2008; 26
Bleau (13) 2009; 4
Schartner (25) 2000; 46
Berezovsky (30) 2014; 16
Wang (40) 2012; 61
Phillips (4) 2006; 9
Rossi (9) 2011; 14
Cardona (18) 2006; 9
Demuth (28) 2007; 6
Yona (29) 2013; 38
Jacquelin (38) 2013; 122
Harrison (17) 1998; 95
Holland (23) 2008; 4
Pamer (34) 2011; 11
Gao (45) 2013; 6
Telford (14) 2013; 946
Bhat (32) 2013; 24
Harrison (37) 2008; 198
Kettenmann (7) 2012; 60
Cancer Genome Atlas Research (2) 2008; 455
Kovacs (19) 2008; 28
Gabrusiewicz (26) 2011; 6
Kracht (27) 2010; 3
Singh (11) 2004; 432
Jung (24) 2000; 20
Holland (22) 2009; 2
43
References_xml – volume: 14
  start-page: 1142
  year: 2011
  ident: 9
  article-title: Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
  publication-title: Nat Neurosci
  doi: 10.1038/nn.2887
  contributor:
    fullname: Rossi
– volume: 468
  start-page: 253
  year: 2010
  ident: 10
  article-title: The myeloid cells of the central nervous system parenchyma
  publication-title: Nature
  doi: 10.1038/nature09615
  contributor:
    fullname: Cardona
– volume: 9
  start-page: 917
  year: 2006
  ident: 18
  article-title: Control of microglial neurotoxicity by the fractalkine receptor
  publication-title: Nat Neurosci
  doi: 10.1038/nn1715
  contributor:
    fullname: Cardona
– volume: 352
  start-page: 987
  year: 2005
  ident: 1
  article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa043330
  contributor:
    fullname: Stupp
– volume: 28
  start-page: 1707
  year: 2008
  ident: 19
  article-title: Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/jcbfm.2008.64
  contributor:
    fullname: Kovacs
– ident: 43
– volume: 106
  start-page: 12530
  year: 2009
  ident: 8
  article-title: Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0804273106
  contributor:
    fullname: Markovic
– volume: 169
  start-page: 2264
  year: 2002
  ident: 42
  article-title: Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.169.5.2264
  contributor:
    fullname: Re
– volume: 198
  start-page: 98
  year: 2008
  ident: 37
  article-title: CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2008.04.016
  contributor:
    fullname: Harrison
– volume: 946
  start-page: 163
  year: 2013
  ident: 14
  article-title: Stem cell identification by DyeCycle Violet side population analysis
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-62703-128-8_11
  contributor:
    fullname: Telford
– volume: 6
  start-page: pl1
  year: 2013
  ident: 45
  article-title: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
  publication-title: Sci Signal
  doi: 10.1126/scisignal.2004088
  contributor:
    fullname: Gao
– volume: 4
  start-page: 226
  year: 2009
  ident: 13
  article-title: PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2009.01.007
  contributor:
    fullname: Bleau
– volume: 3
  start-page: 5
  year: 2012
  ident: 41
  article-title: Interleukin-1beta and transforming growth factor-beta cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells
  publication-title: Stem Cell Res Ther
  doi: 10.1186/scrt96
  contributor:
    fullname: Wang
– volume: 455
  start-page: 1061
  year: 2008
  ident: 2
  article-title: N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways
  publication-title: Nature
  doi: 10.1038/nature07385
  contributor:
    fullname: Cancer Genome Atlas Research
– volume: 4
  start-page: 203
  year: 2008
  ident: 23
  article-title: Glioma formation, cancer stem cells, and akt signaling
  publication-title: Stem Cell Rev
  doi: 10.1007/s12015-008-9021-5
  contributor:
    fullname: Holland
– volume: 61
  start-page: 1085
  year: 2012
  ident: 40
  article-title: Pro-inflammatory cytokine interleukin-1beta promotes the development of intestinal stem cells
  publication-title: Inflamm Res
  doi: 10.1007/s00011-012-0501-3
  contributor:
    fullname: Wang
– volume: 24
  start-page: 331
  year: 2013
  ident: 32
  article-title: Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.08.001
  contributor:
    fullname: Bhat
– volume: 95
  start-page: 10896
  year: 1998
  ident: 17
  article-title: Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.95.18.10896
  contributor:
    fullname: Harrison
– volume: 155
  start-page: 462
  year: 2013
  ident: 5
  article-title: The somatic genomic landscape of glioblastoma
  publication-title: Cell
  doi: 10.1016/j.cell.2013.09.034
  contributor:
    fullname: Brennan
– volume: 2
  start-page: 401
  year: 2012
  ident: 44
  article-title: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-12-0095
  contributor:
    fullname: Cerami
– volume: 68
  start-page: 2241
  year: 2008
  ident: 6
  article-title: Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6350
  contributor:
    fullname: Becher
– volume: 6
  start-page: 1212
  year: 2007
  ident: 28
  article-title: MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-06-0711
  contributor:
    fullname: Demuth
– volume: 16
  start-page: e25
  year: 2014
  ident: 30
  article-title: Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation
  publication-title: Neoplasia
  doi: 10.1016/j.neo.2014.03.006
  contributor:
    fullname: Berezovsky
– volume: 26
  start-page: 5957
  year: 2008
  ident: 36
  article-title: Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.17.2833
  contributor:
    fullname: Rodero
– volume: 20
  start-page: 4106
  year: 2000
  ident: 24
  article-title: Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.20.11.4106-4114.2000
  contributor:
    fullname: Jung
– volume: 17
  start-page: 98
  year: 2010
  ident: 3
  article-title: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2009.12.020
  contributor:
    fullname: Verhaak
– volume: 122
  start-page: 674
  year: 2013
  ident: 38
  article-title: CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice
  publication-title: Blood
  doi: 10.1182/blood-2013-01-480749
  contributor:
    fullname: Jacquelin
– volume: 14
  start-page: 357
  year: 2014
  ident: 12
  article-title: Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2014.01.005
  contributor:
    fullname: Pietras
– volume: 38
  start-page: 79
  year: 2013
  ident: 29
  article-title: Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.12.001
  contributor:
    fullname: Yona
– volume: 330
  start-page: 841
  year: 2010
  ident: 35
  article-title: Fate mapping analysis reveals that adult microglia derive from primitive macrophages
  publication-title: Science
  doi: 10.1126/science.1194637
  contributor:
    fullname: Ginhoux
– volume: 8
  start-page: e57230
  year: 2013
  ident: 39
  article-title: Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0057230
  contributor:
    fullname: Kumar
– volume: 177
  start-page: 2549
  year: 2010
  ident: 20
  article-title: CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2010.100265
  contributor:
    fullname: Lee
– volume: 2
  start-page: 89
  year: 2009
  ident: 22
  article-title: Modeling Adult Gliomas Using RCAS/t-va Technology
  publication-title: Transl Oncol
  doi: 10.1593/tlo.09100
  contributor:
    fullname: Holland
– volume: 60
  start-page: 502
  year: 2012
  ident: 7
  article-title: The brain tumor microenvironment
  publication-title: Glia
  doi: 10.1002/glia.21264
  contributor:
    fullname: Kettenmann
– volume: 3
  start-page: 260
  year: 2013
  ident: 31
  article-title: Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2012.12.013
  contributor:
    fullname: Joo
– volume: 73
  start-page: 303
  year: 2013
  ident: 33
  article-title: Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation
  publication-title: Ann Neurol
  doi: 10.1002/ana.23813
  contributor:
    fullname: Gutmann
– volume: 11
  start-page: 69
  year: 2007
  ident: 15
  article-title: A perivascular niche for brain tumor stem cells
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.11.020
  contributor:
    fullname: Calabrese
– volume: 6
  start-page: 141
  year: 2010
  ident: 16
  article-title: Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2010.01.001
  contributor:
    fullname: Charles
– volume: 32
  start-page: 14592
  year: 2012
  ident: 21
  article-title: The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.0539-12.2012
  contributor:
    fullname: Morganti
– volume: 9
  start-page: 157
  year: 2006
  ident: 4
  article-title: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.02.019
  contributor:
    fullname: Phillips
– volume: 432
  start-page: 396
  year: 2004
  ident: 11
  article-title: Identification of human brain tumour initiating cells
  publication-title: Nature
  doi: 10.1038/nature03128
  contributor:
    fullname: Singh
– volume: 6
  start-page: e23902
  year: 2011
  ident: 26
  article-title: Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0023902
  contributor:
    fullname: Gabrusiewicz
– volume: 3
  start-page: cm2
  year: 2010
  ident: 27
  article-title: Interleukin-1beta (IL-1beta) processing pathway
  publication-title: Sci Signal
  contributor:
    fullname: Kracht
– volume: 11
  start-page: 762
  year: 2011
  ident: 34
  article-title: Monocyte recruitment during infection and inflammation
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3070
  contributor:
    fullname: Pamer
– volume: 46
  start-page: 961
  year: 2000
  ident: 25
  article-title: Flow cytometric characterization of tumor-associated macrophages in experimental gliomas
  publication-title: Neurosurgery
  contributor:
    fullname: Schartner
SSID ssj0000547829
Score 2.512087
Snippet The most abundant populations of non-neoplastic cells in the glioblastoma (GBM) microenvironment are resident microglia, macrophages and infiltrating monocytes...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 15077
SubjectTerms Animals
Brain Neoplasms - genetics
Brain Neoplasms - metabolism
Brain Neoplasms - pathology
Cell Line
CX3C Chemokine Receptor 1
Female
Gene Expression Regulation, Neoplastic
Glioblastoma - genetics
Glioblastoma - metabolism
Glioblastoma - pathology
Humans
Immunoblotting
Interleukin-1beta - genetics
Interleukin-1beta - metabolism
Interleukin-1beta - pharmacology
Macrophages - metabolism
Macrophages - pathology
Male
Mice, Knockout
Mice, Transgenic
Microglia - metabolism
Microglia - pathology
Microscopy, Confocal
Monocytes - metabolism
Monocytes - pathology
Neoplastic Stem Cells - drug effects
Neoplastic Stem Cells - metabolism
p38 Mitogen-Activated Protein Kinases - metabolism
Receptors, Chemokine - genetics
Receptors, Chemokine - metabolism
Receptors, Interleukin-1 Type I - genetics
Receptors, Interleukin-1 Type I - metabolism
Research Paper
Reverse Transcriptase Polymerase Chain Reaction
Survival Analysis
Tumor Cells, Cultured
Tumor Microenvironment - genetics
SummonAdditionalLinks – databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8NAEF60XryI4qu-iODFQ2oem93sQUSKpYh6EAvFS9jsbrTQJrVpwf57Z5L0pfUYslnItzP7zbCz3xBypR0nZkL5tvJialPhSlsC7dq-SCg3rkpk0TPy-YW1O_SxG3QX16MrAPO1qR32k-qM-o3vr-kdOPwtOnzIfO8mQx2DonC64YPFbpItD2W5sJCvCvZLpW8KdCiqs8p1H6IycABJuIs10cs09Sf2_F1CucRJrV2yUwWT1n25-ntkw6T75P0JJrSyxGp2_eara_VSDAxzk1tSqcmgateFA-B3wR4GxTm7BeaYqekYh6XaGhZVevDw0e9lA9hzYEfs5Qek03p4a7btqoOCrSjzxjaQsZKOAYoPKF4zcKUCL9ahzxjXYQAelxgqUHE-TDzhKK60CnVgICcxngF-OyS1NEvNMbF4TIU2LvA915AExiJ2pFY-14ZRFkpdJ9czwKJhKZQRYYKBOEcLnCPEuU4uZ4hGYM14RCFTk03yyGWCcizNCevkqER4PttsaeqEr2A_H4BK2atv0t5noZhNgyB0fX7y75ynZBsioQBrwDznjNTGo4k5h2hjHF8URvQDs2jW8Q
  priority: 102
  providerName: Scholars Portal
Title Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis
URI https://www.ncbi.nlm.nih.gov/pubmed/25987130
https://search.proquest.com/docview/1694705208
https://pubmed.ncbi.nlm.nih.gov/PMC4558137
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFH8kOe1SVrq16UfwYJcdnFi2Po8l9IOxjDEWCL0YWZJXQ22HJjn0v--TY6fJetvFYCwJ89OTfu_xfnoC-GqjKOPKJKGJMxpSRXSokXbDROVUOGJy3dwZOfvJ7-f0-4ItesC6szCNaN9kxbh6KsdV8dhoK5elmXQ6scmv2ZQyJkkiJn3oo4Huhejbgt4UWU-1KUnJk3hS-zoHjbB6nGAHXwCYYaxNvPR5n43euZj_KiX3qOf2Ixy1PmNwvf23Y-i56gQefuCAQZ0H00Uy_U2CovL-38qtAm3Mpmxv5fIN0IZw2ssmnR6g1dXmZe2bVTZYNmI8fPn7VNQlbi248RWrTzC_vfkzvQ_bixJCQ3m8DpFzjY4cMjmj_jQB0QYXq5UJ58JKhgsrd1T5wvIyj1VkhLFGWuYw9HCxQxr7DIOqrtwZBCKjyjqCtC4sxnqZyiJtTSKs45RLbYfwrQMsXW7rYaQ-jvA4p284px7nIXzpEE3RaH0mQleu3qxSwhUVXoEjh3C6RXg3Wjc1QxAH2O8a-ILYh1_QTprC2K1dnP93zwv4gA4R81KwOLqEwfp5467Q6VhnI-jfLQg-Z1SOGoN7BUxF3RQ
link.rule.ids 230,315,730,783,787,888,2228,24332,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTtwwFL2isGg3pagPBlpIpW66SCYPP-JlNepogBmEEKARm8ixnTaCJKNOZkG_vtd50Bm6KsvITuToXPueKx8fA3zRvp8yoSJXhSlxiQikKzHtupHICDeBymRzZ-TsnE2uyemczreA9mdhGtG-SnOvvC-8Mv_ZaCsXhRr2OrHhxWxEKI2DiA9fwA7OV5-tFemtpTfBvCe6TcmYReGwsk4HjbTaizCmrQUwxWo7sOLn9Xz0D8l8qpVcSz7jXbjph91qTu68VZ166vcTR8f__q838Lqjo863tnkPtkz5Fm6nOFKnypzRPBpdBk5eWmq5NEtHKrUqugu_bAcMT4yootmpdzCgK_VQ226ldhaNzg8fftznVYGrFq6p-fIdXI-_X40mbncHg6sIC2sX07mSvkGSQIk9qBBIheuAjiPGuI4pztnMEGE96-MsFL7iSqtYU4NVjQkNZsj3sF1WpdkHh6dEaBMgY-Aay8hUpL7UKuLaMMJiqQfwtUciWbRWG4ktUSyAyV8AEwvgAD73UCU4H-wmhyxNtVomAROEW3FPPIAPLXSPX-sxHwDfAPWxg_Xa3mxBqBrP7Q6ag2e_eQwvJ1ezaTI9OT87hFfIu6hVnIX-R9iuf63MJ-Q2dXrURPIfnSD9Qg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKlW9FCraslBKKvXCIW_Hj2O1sAK6i1AF0opL5NhOG0GSVTd7oL--4zxgoTeOUSaRo2_GMyN_-Qbgmw6CjAoVuyrKiEtEKF2JadeNRU6YCVUu25mRswt6ek3O58l8bdRXS9pXWeFVd6VXFb9bbuWiVP7AE_MvZ2OSJDyMmb_Quf8KXmPMBnytUe9kvQnmPtEfTHIaR35t1Q5aerUXo19bGeAEO-7QEqDXc9J_heZzvuRaAppswc2w9I53cuutmsxTf5-pOr7o27bhXV-WOt87k_ewYaoduJniap06d8bzePwzdIrKlphLs3SkUquyH_xlDdBN0bPK9sTeQceu1X1jzSrtLFq-H178uivqEncv3FuL5Qe4npxcjU_dfhaDqwiNGhfTupKBwWIhIfaHhVAq3A80jyllmicYu7khwmrX8zwSgWJKK64Tg92NiQxmyo-wWdWV2QWHZURoE2LlwDS2k5nIAqlVzLShhHKpR3A0oJEuOsmN1LYqFsT0EcTUgjiCrwNcKcaFPeyQlalXyzSkgjBL8uEj-NTB9_C2AfcRsCfAPhhYze2ndxCuVnu7h2fvxU8ewpvL40k6Pbv4sQ9vsfxKLPEsCj7DZvNnZQ6wxGmyL60z_wN9lv_C
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Loss+of+CX3CR1+increases+accumulation+of+inflammatory+monocytes+and+promotes+gliomagenesis&rft.jtitle=Oncotarget&rft.au=Feng%2C+Xi&rft.au=Szulzewsky%2C+Frank&rft.au=Yerevanian%2C+Alexan&rft.au=Chen%2C+Zhihong&rft.date=2015-06-20&rft.eissn=1949-2553&rft.volume=6&rft.issue=17&rft.spage=15077&rft_id=info:doi/10.18632%2Foncotarget.3730&rft_id=info%3Apmid%2F25987130&rft.externalDocID=25987130
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-2553&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-2553&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-2553&client=summon